Please assess the completion status of the following clinical trial:

Trial Title: Impact of Vitamin D Repletion in Hemodialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \> 18 years~2. Chronic hemodialysis treatments for at least 2 consecutive months~3. 25OH-Vitamin D level \< 25 ng/mL (inclusion criteria for randomization)~Exclusion Criteria:~1. History of acute renal failure requiring dialysis with potential for renal recovery~2. History of HIV/AIDS~3. Inability to provide informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- No treatment (standard of care) (Type: NO_INTERVENTION): Patients will be randomized in a 3:2 ratio to oral Vitamin D treatment, or standard of care (no repletion).
- Vitamin D repletion (Type: EXPERIMENTAL): Patients will be randomized in a 3:2 ratio to oral Vitamin D treatment, or standard of care (no repletion).

Based on this trial design, predict the completion outcome and termination type (if applicable).